YatinVyasMDMBBS

Pediatric Hematology & Oncology • Iowa City, IA

Chair of Pediatrics, Penn State Health Milton S. Hershey Medical Center

Join to view full profile

Dr. Vyas is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Vyas' full profile

Already have an account?

Office
200 Hawkins Dr
Iowa City, IA 52242
Phone+1 319-356-3595

Fax+1 319-356-7659

Education & Training

New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 1995 - 1998
NYU Grossman School of MedicineResidency, Pediatrics, 1993 - 1995
B. J. Medical College AhmedabadClass of 1987

Certifications & Licensure

PA State Medical License 2005 - 2026
IA State Medical License 2013 - 2023
NJ State Medical License 1999 - 2005
NY State Medical License 2002 - 2005
American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

7 citations
Actin nucleators safeguard replication forks by limiting nascent strand degradation.
Jadwiga Nieminuszczy, Peter R Martin, Ronan Broderick, Joanna Krwawicz, Alexandra Kanellou
Nucleic Acids Research. 2023-07-07
3 citations
Actin nucleators safeguard replication forks by limiting nascent strand degradation.
Jadwiga Nieminuszczy, Peter R Martin, Ronan Broderick, Joanna Krwawicz, Alexandra Kanellou
Biorxiv. 2023-01-12
18 citations
WASp modulates RPA function on single-stranded DNA in response to replication stress and DNA damage.
Seong-Su Han, Kuo-Kuang Wen, María L García-Rubio, Marc S Wold, Andrés Aguilera
Nature Communications. 2022-06-29

Press Mentions

$Senhwa Biosciences Announces First Patient Dosed in the Phase I/II Study of Silmitasertib in Children and Young Adults with Relapsed Refractory Solid Tumors$
Senhwa Biosciences Announces First Patient Dosed in the Phase I/II Study of Silmitasertib in Children and Young Adults with Relapsed Refractory Solid TumorsNovember 6th, 2024
Penn State Health Children’s Hospital Ranks Among Nation's Best in Two SpecialtiesOctober 8th, 2024
Penn State Health Children’s Hospital Ranks Among Best in NationOctober 8th, 2024
Join now to see all